GGrantIndex
← Leaderboards

Allison E Ashley-Koch

Duke University

$11,363,445
Attributed
$13,982,374
Total exposure
10
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.3M · FY200525
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$13,982,374 · 10

By mechanism

R01$8,816,165 · 5
T32$2,569,941 · 1
R21$1,316,456 · 3
P01$1,279,812 · 1

Most similar at Duke University

Same institution · by research overlap

Others in their field

Top investigators on “Genetic

Research focus

GeneticPhenotypeGenomicsAffectEtiologyGenesVariantBaseFamilyCandidate Disease GeneSamplingGenotypeCohortBiologicalSymptomsGenome Wide Association StudyComplexHereditary DiseaseSickle Cell AnemiaFrequencies (Time Pattern)NumbersAdultMapsPathway Interactions

Grant awards (32)

Advancing a Holistic Understanding of Variability in Lived Experience with Sickle Cell Pain$1,049,682
R01 · FY2025 · HL
Genetics and Genomics Training Grant$549,359
T32 · FY2024 · GM · contact PI
'Omics predictors of Sickle Cell Severity and Survival$430,956
R21 · FY2024 · AG · contact PI
Genetics and Genomics Training Grant$530,535
T32 · FY2023 · GM · contact PI
Epigenetic Age Acceleration and Psychoneurological Symptoms in Sickle Cell Disease$201,250
R21 · FY2023 · NR
Genetics and Genomics Training Grant$520,362
T32 · FY2022 · GM · contact PI
Epigenetic Age Acceleration and Psychoneurological Symptoms in Sickle Cell Disease$241,500
R21 · FY2022 · NR
Identifying novel clinical, genetic and proteomic risk factors for sickle cell nephropathy.$161,000
R21 · FY2022 · DK · contact PI
Genetics and Genomics Training Grant$487,629
T32 · FY2021 · GM · contact PI
Identifying novel clinical, genetic and proteomic risk factors for sickle cell nephropathy.$281,750
R21 · FY2021 · DK · contact PI
Genetics and Genomics Training Grant$482,056
T32 · FY2020 · GM · contact PI
Transcriptomic, therapeutic and genetic investigations of sickle cell nephropathy$238,500
R01 · FY2018 · DK · contact PI
Transcriptomic, therapeutic and genetic investigations of sickle cell nephropathy$238,500
R01 · FY2017 · DK · contact PI
Transcriptomic, therapeutic and genetic investigations of sickle cell nephropathy$238,500
R01 · FY2016 · DK · contact PI
Linkage and candidate gene analysis in non-syndromic Chiari type I$340,905
R01 · FY2013 · NS · contact PI
Linkage and candidate gene analysis in non-syndromic Chiari type I$389,005
R01 · FY2012 · NS · contact PI
Linkage and candidate gene analysis in non-syndromic Chiari type I$368,351
R01 · FY2011 · NS · contact PI
Linkage and candidate gene analysis in non-syndromic Chiari type I$449,863
R01 · FY2010 · NS · contact PI
Linkage and candidate gene analysis in non-syndromic Chiari type I$421,037
R01 · FY2009 · NS · contact PI
The Hereditary Basis of Neural Tube Defects$783,041
R01 · FY2008 · NS · contact PI
Candidate Gene Analysis of Persistent AD/HD$542,464
R01 · FY2008 · NS · contact PI
CORE--INFORMATICS$321,953
P01 · FY2008 · HL · contact PI
The Hereditary Basis of Neural Tube Defects$799,699
R01 · FY2007 · NS · contact PI
Candidate Gene Analysis of Persistent AD/HD$582,135
R01 · FY2007 · NS · contact PI
The Hereditary Basis of Neural Tube Defects$549,979
R01 · FY2007 · NS · contact PI
CORE--INFORMATICS$325,860
P01 · FY2007 · HL · contact PI
Candidate Gene Analysis of Persistent AD/HD$596,945
R01 · FY2006 · NS · contact PI
CORE E-INFORMATICS$199,441
P01 · FY2006 · HL · contact PI
Candidate Gene Analysis of Persistent AD/HD$615,998
R01 · FY2005 · NS
CORE E-INFORMATICS$196,733
P01 · FY2005 · HL
Candidate Gene Analysis of Persistent AD/HD$611,561
R01 · FY2004 · NS
CORE E-INFORMATICS$235,825
P01 · FY2004 · HL